These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 12015035

  • 41. Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance.
    Pircher A, Kähler CM, Skvortsov S, Dlaska M, Kawaguchi G, Schmid T, Gunsilius E, Hilbe W.
    Oncol Rep; 2008 Feb; 19(2):345-52. PubMed ID: 18202780
    [Abstract] [Full Text] [Related]

  • 42. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
    Li Q, Dong X, Gu W, Qiu X, Wang E.
    Chin Med J (Engl); 2003 May; 116(5):727-30. PubMed ID: 12875690
    [Abstract] [Full Text] [Related]

  • 43. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [Abstract] [Full Text] [Related]

  • 44. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
    Saji H, Nakamura H, Awut I, Kawasaki N, Hagiwara M, Ogata A, Hosaka M, Saijo T, Kato Y, Kato H.
    Ann Thorac Cardiovasc Surg; 2003 Oct 15; 9(5):295-300. PubMed ID: 14672525
    [Abstract] [Full Text] [Related]

  • 45. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T.
    Eur J Cardiothorac Surg; 2004 Mar 15; 25(3):443-8. PubMed ID: 15019676
    [Abstract] [Full Text] [Related]

  • 46. [Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer].
    Li J, Li BL, Zhang HQ, Xu SF, Liu ZD, Yue WT, Han Y.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 18; 88(42):2982-5. PubMed ID: 19080076
    [Abstract] [Full Text] [Related]

  • 47. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 48. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 01; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 49. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T, Huang CL, Liu D, Kameyama K, Masuya D, Ueno M, Haba R, Yokomise H.
    Med Sci Monit; 2004 Jun 01; 10(6):BR157-65. PubMed ID: 15173661
    [Abstract] [Full Text] [Related]

  • 50. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
    Laack E, Scheffler A, Burkholder I, Boeters I, Andritzky B, Schuch G, Görn M, Vohwinkel G, Edler L, Fiedler W, Hossfeld DK.
    Lung Cancer; 2005 Oct 01; 50(1):51-8. PubMed ID: 15992959
    [Abstract] [Full Text] [Related]

  • 51. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, Peck K.
    Clin Cancer Res; 2005 Jan 01; 11(1):173-9. PubMed ID: 15671543
    [Abstract] [Full Text] [Related]

  • 52. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
    Yie SM, Lou B, Ye SR, He X, Cao M, Xie K, Ye NY, Lin R, Wu SM, Xiao HB, Gao E.
    Lung Cancer; 2009 Feb 01; 63(2):284-90. PubMed ID: 18606477
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance].
    Zhang HZ, Hua P, Li HG, Lü ZQ, Zeng YJ, Liu JG, Zeng H.
    Zhonghua Zhong Liu Za Zhi; 2005 Dec 01; 27(12):734-7. PubMed ID: 16483484
    [Abstract] [Full Text] [Related]

  • 55. [The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer].
    Sağlam DA, Ursavaş A, Karadağ M, Yilmaztepe Oral A, Coşkun F, Gözü RO.
    Tuberk Toraks; 2008 Dec 01; 56(1):50-5. PubMed ID: 18330755
    [Abstract] [Full Text] [Related]

  • 56. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH, Wang Z, Li Q, Li FR, Qi H, Zhou HX.
    Zhonghua Zhong Liu Za Zhi; 2007 Sep 01; 29(9):676-80. PubMed ID: 18246797
    [Abstract] [Full Text] [Related]

  • 57. Vascular endothelial growth factor in angiosarcoma.
    Fujimoto M, Kiyosawa T, Murata S, Matsuo K, Suzuki H, Sone H, Okuda Y, Nakayama Y, Yaoita H.
    Anticancer Res; 1998 Sep 01; 18(5B):3725-9. PubMed ID: 9854484
    [Abstract] [Full Text] [Related]

  • 58. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
    Belgore FM, Lip GY, Bareford D, Wadley M, Stonelake P, Blann AD.
    Am J Hematol; 2001 Jan 01; 66(1):59-61. PubMed ID: 11426496
    [Abstract] [Full Text] [Related]

  • 59. Vascular endothelial growth factor (VEGF) serum levels are associated with survival in early stages of lung cancer patients.
    Carrillo-de Santa Pau E, Carrillo Arias F, Caso Pelaez E, Muguruza Trueba I, Sánchez Hernández I, Muñoz Molina GM, Moreno Balsalobre R, Sacristán López S, Gómez-Pinillos A, Toledo Lobo Mdel V.
    Cancer Invest; 2010 May 01; 28(4):393-8. PubMed ID: 19968501
    [Abstract] [Full Text] [Related]

  • 60. Angiostatin expression in non-small cell lung cancer.
    Volm M, Mattern J, Koomägi R.
    Clin Cancer Res; 2000 Aug 01; 6(8):3236-40. PubMed ID: 10955809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.